Case Study

Using De-Identified Linked Real-World Data To Create An External Control Arm

Source: Datavant
iStock-1254724342-doctor-xray-lung-chest-patient

A Pharmaceutical company designed its Phase II study of a novel agent to treat metastatic non-small cell lung cancer driven by a rare subtype of EGFR genetic mutation. This type of lung cancer only affected a small subset of EGFR patients, therefore designing studies and finding patients for clinical trials was difficult. The client decided that constructing a control arm out of real-world electronic health record data would be the best approach to the trial. This case study examines how utilizing a platform that allowed them to collect data across three vendors that represented unique patients proved successful and enabled the company to move forwards with the Phase II pivotal trial.

VIEW THE CASE STUDY!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Clinical Leader